Obesity

weight loss scale weigh measure tape obesity overweight

Biotech

Zealand's dual agonist tied to 11% weight loss in phase 1b

A higher dose of Zealand Pharma's GLP-1/GLP-2 receptor dual agonist reduced mean body weight by 11.6% after 28 weeks in a phase 1b trial.

Gabrielle Masson Jun 18, 2025 3:00pm

obesity overweight weight loss weigh

Scholar Rock's SMA drug helps Zepbound patients retain muscle

Jun 18, 2025 9:10am

Istanbul Turkey aerial view

Turkish bank invests $39M in Harvard next-gen obesity antibodies

Jun 16, 2025 1:07pm

liver

South Korean biotech's GLP-1 scores MASH win, reduces weight

Jun 16, 2025 7:22am

Ozempic syringe pen and measuring tape on blue background

Novo plots ph. 3 trials for next-gen obesity asset amycretin

Jun 13, 2025 10:35am

Anatomical model of human arm and torso showing muscle

Eli Lilly inks $650M Juvena pact to find muscle-boosting drugs

Jun 11, 2025 7:30am